A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infectionTarek Hassanein, David Gardiner, Eric Lawitz et al.|Journal of Hepatology|2015Cited by 53
P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTIONTarek Hassanein, David Gardiner, Karen Sims et al.|Journal of Hepatology|2014Cited by 12